CorMedix Inc. 19KA.F Stock
CorMedix Inc. Price Chart
CorMedix Inc. 19KA.F Financial and Trading Overview
| CorMedix Inc. stock price | 4.66 EUR |
| Previous Close | 4.92 EUR |
| Open | 4.66 EUR |
| Bid | 4.66 EUR x 0 |
| Ask | 4.82 EUR x 0 |
| Day's Range | 4.66 - 4.66 EUR |
| 52 Week Range | 2.56 - 6.89 EUR |
| Volume | 1.1K EUR |
| Avg. Volume | 6 EUR |
| Market Cap | 211.46M EUR |
| Beta (5Y Monthly) | 2.160915 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.85 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 21.25 EUR |
19KA.F Valuation Measures
| Enterprise Value | 168.32M EUR |
| Trailing P/E | N/A |
| Forward P/E | -5.6144576 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3660.26 |
| Price/Book (mrq) | 3.8448844 |
| Enterprise Value/Revenue | 2913.534 |
| Enterprise Value/EBITDA | -4.875 |
Trading Information
CorMedix Inc. Stock Price History
| Beta (5Y Monthly) | 2.160915 |
| 52-Week Change | 103.36% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 6.89 EUR |
| 52 Week Low | 2.56 EUR |
| 50-Day Moving Average | 4.32 EUR |
| 200-Day Moving Average | 3.74 EUR |
19KA.F Share Statistics
| Avg. Volume (3 month) | 6 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 45.38M |
| Float | 44.74M |
| Short Ratio | N/A |
| % Held by Insiders | 1.08% |
| % Held by Institutions | 25.63% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -59905.80% |
| Gross Margin | 96.17% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -34.84% |
| Return on Equity (ttm) | -58.41% |
Income Statement
| Revenue (ttm) | 57.77K EUR |
| Revenue Per Share (ttm) | 0.001 EUR |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 61.67K EUR |
| EBITDA | -34527556 EUR |
| Net Income Avi to Common (ttm) | -33234736 EUR |
| Diluted EPS (ttm) | -0.8 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 55.6M EUR |
| Total Cash Per Share (mrq) | 1.23 EUR |
| Total Debt (mrq) | 770.01K EUR |
| Total Debt/Equity (mrq) | 1.43 EUR |
| Current Ratio (mrq) | 12.147 |
| Book Value Per Share (mrq) | 1.212 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -28006276 EUR |
| Levered Free Cash Flow (ttm) | -16648976 EUR |
Profile of CorMedix Inc.
| Country | Germany |
| State | NJ |
| City | Berkeley Heights |
| Address | 300 Connell Drive |
| ZIP | 07922 |
| Phone | 908 517 9500 |
| Website | https://www.cormedix.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 40 |
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath and Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Q&A For CorMedix Inc. Stock
What is a current 19KA.F stock price?
CorMedix Inc. 19KA.F stock price today per share is 4.66 EUR.
How to purchase CorMedix Inc. stock?
You can buy 19KA.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CorMedix Inc.?
The stock symbol or ticker of CorMedix Inc. is 19KA.F.
Which industry does the CorMedix Inc. company belong to?
The CorMedix Inc. industry is Biotechnology.
How many shares does CorMedix Inc. have in circulation?
The max supply of CorMedix Inc. shares is 55.56M.
What is CorMedix Inc. Price to Earnings Ratio (PE Ratio)?
CorMedix Inc. PE Ratio is now.
What was CorMedix Inc. earnings per share over the trailing 12 months (TTM)?
CorMedix Inc. EPS is -0.85 EUR over the trailing 12 months.
Which sector does the CorMedix Inc. company belong to?
The CorMedix Inc. sector is Healthcare.